Projects funded by the NCN
Suppression of platelet activation as a therapeutic target for patients with AERD (aspirin-exacerbated respiratory disease).
2017/25/B/NZ5/01518
Keywords:
Aspirin-exacerbated respiratory disease platelet–leukocyte aggregates platelet activation biomarkers clopidogrel aspirin challenge
Descriptors:
- NZ5_3: Pathogenesis of human diseases
- NZ5_5: Diagnostics in human diseases
- NZ5_7: Human disease treatment
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Uniwersytet Jagielloński – Collegium Medicum, Collegium Medicum, Wydział Lekarski
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 7
Call: OPUS 13 - announced on 2017-03-15
Amount awarded: 1 196 300 PLN
Project start date (Y-m-d): 2018-02-13
Project end date (Y-m-d): 2021-02-10
Project duration:: 36 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Nebulizator ultradzwiękowy Equipment name and justification of purchase: (4 500 PLN)
- System RP PCR typu: QuantStudio™12K Flex System (433 000 PLN)